Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T07861
(Former ID: TTDI01156)
|
|||||
Target Name |
IL-1 synthesis/release (IL-1 synth/rele)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Asthma [ICD-11: CA23] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | Flezelastine | Drug Info | Phase 2 | Asthma | [1] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | Flezelastine | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Effects of flezelastine and its enantiomers on LPS-induced IL-1 beta generation in vitro and LPS-induced pyrexia in vivo. Agents Actions. 1994 Mar;41(1-2):99-100. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.